MAGELLAN LONGEVITY
HomeResearchStudy library › What are the molecular events linking a healthy food pattern to…
Study summary · Cardiovascular & vascular aging

What are the molecular events linking a healthy food pattern to reduced risk of cardiometabolic disease?

In one paragraph

Ergothioneine, studied in 3236 participants (Heart 2019, PMID 31672783) — during a median follow-up of 21.4 years, 603 participants developed CVD, 362 developed diabetes mellitus, and 843 died. The study identified associations but did not establish causality between ergothioneine levels and reduced risk.

Source: Heart 2019, PMID 31672783 ↗ · Research map · How Magellan grades evidence · evidence confidence: high

Heart · 2019 · PMID 31672783 · DOI 10.1136/heartjnl-2019-315485

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Higher levels of the metabolite ergothioneine are linked to a lower risk of heart disease, diabetes, and death.

The question

What are the molecular events linking a healthy food pattern to reduced risk of cardiometabolic disease?

What they tested

Plasma metabolites associated with a health conscious food pattern (HCFP) will predict cardiometabolic disease and mortality.

How they did it

Plasma levels of 112 metabolites were measured in 3236 participants from the Malmö Diet and Cancer study using liquid-chromatography mass-spectrometry. Participants had no history of cardiovascular disease or diabetes. Multivariable adjusted linear regressions identified metabolites associated with the HCFP. These biomarkers were then related to the risk of cardiometabolic disease and mortality using multivariable adjusted Cox proportional hazards models during long-term follow-up.

What they found

During a median follow-up of 21.4 years, 603 participants developed CVD, 362 developed diabetes mellitus, and 843 died. Five healthy dietary biomarkers were associated with the HCFP at baseline, and four of these predicted at least one of the studied endpoints. Ergothioneine was the metabolite most strongly connected to the HCFP and was associated with a lower risk of coronary disease (HR=0.85), cardiovascular mortality (HR=0.79), and overall mortality (HR=0.86) per 1 SD increment.

Ergothioneine and Risk Reduction
Values shown: Hazard Ratio
Coronary Disease0.85
Cardiovascular Mortality0.79
Overall Mortality0.86

Hazard Ratios (HR) for outcomes per 1 standard deviation increment of plasma ergothioneine.

What it means

Higher plasma ergothioneine is an independent marker of lower risk of cardiometabolic disease and mortality, potentially influenced by a healthy dietary intake.

Limitations

The study identified associations but did not establish causality between ergothioneine levels and reduced risk. The specific dietary components of the HCFP that induce higher ergothioneine were not detailed.

“higher ergothioneine was an independent marker of lower risk of cardiometabolic disease and mortality”— from the published abstract, Heart 2019

The paper at a glance

Magellan’s evidence labelplasma ergothioneine, cytoprotection (our label for this citation — see PubMed for the paper’s own title and authors)
JournalHeart
Year2019
PMID31672783 ↗
DOI10.1136/heartjnl-2019-315485 ↗
TopicCardiovascular & vascular aging

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Ergothioneine (L-Ergo)

In humans, blood ergothioneine levels tend to fall with age, particularly after 60, and multiple observational and prospective studies link lower plasma ergothioneine to a higher risk of cognitive decline, dementia, cardiovascular disease, frailty and overall mortality;

Ergothioneine (L-Ergo)

Ergothioneine (L-ergothioneine, "L-Ergo") is a naturally occurring sulfur-containing amino acid (a…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). What are the molecular events linking a healthy food pattern to reduced risk of cardiometabolic disease? [Plain-English summary of Heart 2019, PMID 31672783, DOI 10.1136/heartjnl-2019-315485]. Magellan Longevity. https://magellanlongevity.com/study/s108.html
BibTeX
@misc{magellan_s108, title = {What are the molecular events linking a healthy food pattern to reduced risk of cardiometabolic disease?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/s108.html}}, note = {Plain-English summary of PubMed PMID 31672783; DOI 10.1136/heartjnl-2019-315485; Heart 2019. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/s108.html

Related studies in the Magellan library

All 67 Magellan summaries on cardiovascular & vascular aging →

How this summary was made. Every section above restates what the published abstract of PMID 31672783 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.